Enhanced ICOS Signaling Between Dendritic Cells and T Cells Characterizes the Immune Landscape of Human Cholangiocarcinoma
Human Mutation · 2025
DOI: 10.1155/humu/9981470 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Mutation, 2025. Verfasst von Meiying Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Digestive Endoscopic Center, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Inducible T-Cell Co-Stimulator Protein, Signal Transduction, Dendritic Cells. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Jiao Tong University.
Abstract (Originalsprache)
Cholangiocarcinoma exhibits a complex tumor microenvironment, yet the cellular interactions governing its progression remain poorly understood. Here, through integrated analysis of two independent single‐cell RNA sequencing datasets comprising both complete tissue and immune‐focused profiling, we comprehensively mapped the cellular landscape and intercellular communication networks in human cholangiocarcinoma. Our analysis revealed significant remodeling of immune cell compositions and interaction patterns in the tumor microenvironment. Notably, we identified enhanced ICOS signaling between dendritic cells and T cells as a prominent feature of cholangiocarcinoma. Using CellChat analysis, we demonstrated that tumor‐associated dendritic cells, particularly plasmacytoid DCs, exhibit stronger ICOS‐mediated communication with T cells compared to their counterparts in normal tissues. Functional validation experiments confirmed that tumor‐conditioned dendritic cells upregulate ICOSL expression and promote CD8+ T‐cell activation through the ICOS–ICOSL axis, as evidenced by increased CD69 and CD25 expression. This activation was specifically abolished by ICOSL blockade, establishing the functional significance of this pathway. Our findings provide novel insights into tumor‐immune interactions in cholangiocarcinoma and suggest the ICOS–ICOSL axis as a potential therapeutic target for immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Digestive Endoscopic Center, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Infectious Diseases Department, Harbin Sixth Hospital, Harbin, Heilongjiang, China.
- Department of General Surgery, Shanghai Eighth People's Hospital, Shanghai, China.
- Department of Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
ORCID-Profile: Meiying Zhu, Yuou Li, Xiaolong Tang, Xinjian Wan, Zunqiang Zhou
Förderung
- National Natural Science Foundation of China
- Shanghai Jiao Tong University
Zitieren
APA
Zhu, M., Li, Y., Tang, X., Wan, X., & Zhou, Z. (2025). Enhanced ICOS Signaling Between Dendritic Cells and T Cells Characterizes the Immune Landscape of Human Cholangiocarcinoma. Human Mutation. https://doi.org/10.1155/humu/9981470
Vancouver
Zhu M, Li Y, Tang X, Wan X, Zhou Z. Enhanced ICOS Signaling Between Dendritic Cells and T Cells Characterizes the Immune Landscape of Human Cholangiocarcinoma. Human Mutation. 2025. doi:10.1155/humu/9981470
BibTeX
@article{Zhu2025,
author = {Zhu, Meiying and Li, Yuou and Tang, Xiaolong and Wan, Xinjian and Zhou, Zunqiang},
title = {Enhanced ICOS Signaling Between Dendritic Cells and T Cells Characterizes the Immune Landscape of Human Cholangiocarcinoma},
journal = {Human Mutation},
year = {2025},
doi = {10.1155/humu/9981470}
}
EUVIMED